Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01130285 · ClinicalTrials.gov registry record
Validation of a Multi-gene Test for Lung Cancer Risk
A clinical trial of Lung Cancer, sponsored by University of Toledo Health Science Campus.
- Active
- Registry status
- 403
- Enrollment target
- 13
- Study locations
NCT01130285 is a study of Lung Cancer that is active but no longer recruiting, run by University of Toledo Health Science Campus. The registered enrollment target is 403 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (57% lower). The trial reports 13 study locations across 7 states.
The verdict
NCT01130285, a study of Lung Cancer, is active but no longer recruiting, sponsored by University of Toledo Health Science Campus.
- ACTIVE NOT RECRUITING
- Registry status
- 403 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of this study is to determine the validity of a multi-gene Lung Cancer Risk Test (LCRT). In the process, the investigators will establish a bank of NBEC samples and corresponding blood samples from individuals demographically at increased risk for lung cancer.
Conditions Studied
Interventions
- GENETIC Lung Cancer Risk Test
Study Locations (13)
Ohio
- Cleveland Clinic Foundation - Cleveland
- Ohio State University - Columbus
- The Toledo Hospital - Toledo
- Mercy St. Vincent Medical Center - Toledo
- University of Toledo, Health Science Campus - Toledo
Michigan
- University of Michigan - Ann Arbor
- Henry Ford - Detroit
Tennessee
- Tennessee Valley Veterans Admin. - Nashville
- Vanderbilt - Nashville
Colorado
- National Jewish Health - Denver
Minnesota
- Mayo Clinic - Rochester
South Carolina
- Medical University of South Carolina - Charleston
Virginia
- Inova Fairfax Hospital - Falls Church
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 403 participants |
| Start Date | 2011-05 |
| Est. Completion | 2026-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01130285
The ClinicalTrials.gov registry entry for NCT01130285 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 403 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (57% lower). The listed sponsor is University of Toledo Health Science Campus, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Lung Cancer Risk Test is the first listed.
NCT01130285 reports 13 study locations spanning 7 distinct geographic areas - top geographies include Ohio, Michigan, Tennessee.
Frequently Asked Questions
What is clinical trial NCT01130285 about?
NCT01130285 is a clinical study titled "Validation of a Multi-gene Test for Lung Cancer Risk". The purpose of this study is to determine the validity of a multi-gene Lung Cancer Risk Test (LCRT). In the process, the investigators will establish a bank of NBEC samples and corresponding blood samples from individuals demographically at increased risk for lung cancer.
What is the current status of trial NCT01130285?
This trial is currently active not recruiting. The enrollment target is 403 participants. The study started on 2011-05. Estimated completion is 2026-09.
What conditions does trial NCT01130285 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT01130285?
The interventions under investigation include: Lung Cancer Risk Test (GENETIC).
Who is sponsoring clinical trial NCT01130285?
This trial is sponsored by University of Toledo Health Science Campus, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01130285 being conducted?
This trial has 13 study locations across Colorado, Michigan, Minnesota, Ohio, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.